Jamie Capal, MD, whose specializes in intellectual and developmental disabilities, will serve chief of the Division of Child Neurology at Golisano Children’s Hospital.
The study demonstrates that calcium and chloride channelopathy lies at the heart of the muscle dysfunction found in the disease and that common clinically available calcium channel blockers can ...
New research appearing in the journal Nature shows that a cocktail of drugs already approved to treat high blood pressure quickly reduces cerebral edema and improves outcomes in animal models of ...
For almost five decades, researchers with the Medical Center have been studying myotonic dystrophy, Duchenne muscular dystrophy, and other rare neuromuscular disorders, and played a pivotal role in ...
The FDA has approved valbenazine as a treatment for Huntington’s disease chorea. A team of URMC researcher provided scientific, technical, logistical, and operational support for the phase 3 study ...
The da Vinci single port robotic surgical system, which made its clinical debut in 2018, represents a significant technological advance in robotic surgery.
New study answers important questions about the viability of treatments that seek to replace diseased and aged cells in the central nervous system with healthy ones.
Only 18 percent of COVID cases in nursing homes received antiviral treatment, despite the known benefit of these drugs and the high risk of nursing home residents to adverse outcomes due to COVID.
An international team of researchers has developed a new method to deliver drugs into the cochlea, repair inner ear hair cells, and restore hearing in deaf mice.
In a review commissioned by the journal Lancet Neurology, an international team of experts argue that current models of care do not adequately address the needs of people living with neurologic ...
Scientists have created one of the most detailed 3D images of the synapse, a technical achievement that allows researchers to study the different cells that converge at individual synapses at a level ...
Eight years ago, University of Rochester Medical Center (URMC) researchers helped launch the first smartphone application designed to track the symptoms of Parkinson’s disease. Apple featured the ...
URMC neurologist Irene Richard, MD, discusses the importance of a recently discovered protein biomarker that can accurately identify Parkinson’s disease, even in undiagnosed and pre-symptomatic ...
The University of Rochester’s leadership in the field of environmental medicine stretches back to toxicology research programs developed at the University under the Manhattan Project. These programs ...
UR Medicine neurologists are now providing 24/7 remote stroke and neurological care for 16 hospitals across upstate New York, creating one of the more comprehensive hub-and-spoke networks in the ...
A new study in NEJM shows that nursing homes that conducted staff surveillance testing more regularly experienced significantly lower rates of COVID infections and deaths.
An international team of neurologists makes the case that the chemical trichloroethylene (TCE), a common pollutant found in contaminated sites, is driving the global growth in Parkinson’s.
U.S. and Zambian researchers and clinicians have building a decades-long partnership to address he neurological burden of diseases like cerebral malaria, HIV, and stroke in Sub-Saharan Africa.
The previously unknown component of brain anatomy, described in the journal Science, acts as both a protective barrier and platform from which immune cells scan the brain for infection and ...
A team of U.S. and German researchers engineered mitochondria that can covert light energy to chemical energy, power cellular functions, and extend life in the roundworm C. elegans. The findings ...
Anton Porsteinsson, M.D., discusses results from a clinical trial for an experimental drug for Alzheimer’s, who benefits, and how the drug is an advance in care.
The Center for Health + Technology will partner with the Defense Department to develop tools that will allow patients to provide insight into the merit of promising therapies for four chronic, ...
A new $3.7 million grant will allow researchers to more precisely understand how the virus triggers damage in the brain and the long-term impact on cognitive performance.
New research shows that a device that passively monitors breathing during sleep can detect Parkinson's and track the progression of the disease over time.
A new $15 million grant from the NIH will bring together several teams of researchers to accelerate our understanding of the complex mechanics that control the brain's unique waste removal system, ...
Rachael Muggleton was a pre-med student at Penn State when a dangerous brain inflammation called autoimmune encephalitis suddenly struck. Her 6-month stay at Strong Memorial Hospital and the ...
Opioid-related deaths jumped more than 28 percent in the first year of the pandemic. A new grant will examine how COVID disruptions contributed to the increase and what can be done to reverse this ...
New research appearing in JAMA Surgery shows that scientific statements intended to lower risk for perioperative stroke may be too conservative, potentially resulting in unnecessary surgical delays.
URMC and Sana Biotechnology have entered into an agreement which will allow Sana to expand its manufacturing footprint and create new job opportunities in Rochester.
The new campus will open its doors to patients on May 16, strengthening the health system’s commitment to increase access to specialist and primary care for patients in Genesee, Orleans, and Wyoming ...
New research shows that assisted living residents on Medicare/Medicaid who reside in states with looser oversight are less likely to die at home under hospice care, an important indicator of the ...
A new documentary, titled The Long Road to Hope, tells the story of individuals with Parkinson’s and efforts to study, treat, and prevent the disease from a global perspective.
New research published in JAMA recommends daily steroid doses for children with Duchenne muscular dystrophy, marking a significant change in how the disease is treated.
Chad Heatwole, M.D., M.S., has been appointed the new director of the Center for Health + Technology (CHeT) at the University of Rochester, one of the nation's leading academic centers in clinical ...
New research links shale gas development in Pennsylvania to pollution of public water supplies and negative impacts on infant health. The findings call for closer environmental regulation of the ...
Results are in! URMC-led study shows that current COVID boosters elicited weak immune responses to new COVID variants, suggesting a need for continued monitoring for new variants and possibly ...
John Markman, M.D., has been named the 2022 Mitchell Max Scientific Award recipient for his contributions to pain research by the American Academy of Neurology.
Ann Falsey, M.D., addresses the question of what life may look like once COVID takes its place among other circulating respiratory diseases that, while dangerous for some, do not produce spikes in ...
Two Air Force Military Medical Teams have been deployed to support clinical operations at UR Medicine’s Strong Memorial Hospital. The militarily personnel will begin service in medical-surgical, ...
Last summer, a blood vessel in Daniel Brito's brain burst during a Triple-A game in Rochester. A new article in The Athletic tells the story of the months-long stay in the Neuro-ICU at URMC and his ...
Children in Rochester were recently among the first in the nation to be enrolled in a phase 3 clinical trial for a new gene therapy to treat Duchenne muscular dystrophy (DMD).
Results of a global research project indicate that trust in science is the most powerful determinant of whether a person will decide to get a COVID vaccine.
A new study by researchers with the University of Rochester Center for Heath + Technology details the experience with three large remote clinical trials in Parkinson's disease and the lessons that ...
The journal Nature Medicine has identified a phase 3 study of pridopidine as a treatment for Huntington’s disease as one of 11 clinical trials that will shape medicine in 2022.
A series of new studies from researchers at URMC indicate that mercury exposure may disrupt the early development of the connections between muscles and the brain, which could lead to motor control ...
URMC will serve as the lead study site in the U.S. for an experimental treatment being developed by Neurogene for CLN5 Batten disease, a rare and fatal neurodegenerative disorder.
UR Medicine’s Comprehensive Stroke Center was honored for providing lifesaving care, including the administration of interventions capable of improving outcomes, especially when provided as soon as ...
Housing policies established more than eight decades ago that effectively trapped people of color in low income and segregated neighborhoods continues to impact the health of residents, resulting in ...
In a perspective piece that appears in the journal Science, Elaine Hill, Ph.D., calls for tighter regulation and monitoring of fracking as more evidence points to the negative health consequences of ...
The federal Food and Drug Administration today granted full approval to the COVID vaccine developed by Pfizer-BioNTech for people 16 and older, making it the first to move beyond emergency use ...
The Program for Translational Brain Mapping that represents a unique nexus between science and neurosurgery to improve care and outcomes. It brings together neuroscientists and neurosurgeons to ...
Former URMC CEO Bradford C. Berk reflects on his own spinal cord injury that left him a quadriplegic and details his experience – as a doctor and a patient – to create a user’s manual for those ...
New research shows that people nursing homes with higher concentrations of Black and Latino residents were more than 50% more likely to be infected with COVID and twice as likely to die in the first ...
New findings from the Adolescent Brain Cognitive Development Study (ABCD) provide researchers with a roadmap of brain activity that could be used to identify cognitive processing problems that could ...
URMC is participating in a new clinical trial that will help inform public health decisions around re-vaccination schedules and the deployment of boosters that target COVID variants.
URMC neurologist Gretchen Birbeck, M.D., M.P.H., has received a $4.3 million award from the NIH to continue her research in sub-Saharan Africa on the neurological problems that arise in people ...
The University of Rochester Environmental Health Sciences Center has received a $7.7 million, five-year renewal grant from the National Institute of Environmental Health Science. The grant marks five ...
Deerfield Management Company, a healthcare investment firm, and Empire Discovery Institute have established a new $65 million research fund to accelerate the translation of scientific discoveries ...
In New York State unconventional natural gas development – or fracking – is banned, while in Pennsylvania it represents a multi-billion dollar industry. New research takes advantage of this ‘natural ...
It’s too soon to know with certainty, but experience with other infectious diseases leads experts to believe that your immune system will probably be able to detect and respond to the coronavirus for ...
URMC is involved in several new initiatives to improve access and equity in COVID vaccine distribution in underserved portions of the City of Rochester and the Finger Lakes region.
Interim study data released today show that the Pfizer-BioNTech coronavirus vaccine is 100% effective in preventing infections in 12-15 year olds. The vaccine is currently approved for emergency use ...
UR Medicine has begun vaccinating at-risk patients who are in the process of being discharged from Strong Memorial Hospital. The effort is part of a New York State initiative announced earlier this ...
URMC and RRH have begun a new clinical trial that will evaluate the safety and efficacy of a third dose of the Pfizer/BioNTech COVID-19 vaccine. This study represents an important step in the ...
Progressive vision loss, and eventually blindness, are the hallmarks of juvenile neuronal ceroid lipofuscinosis (JNCL) or CLN3-Batten disease. New research shows how the mutation associated with the ...
An interim analysis of study data from a coronavirus vaccine being developed by Pfizer and BioNTech indicates that the vaccine is highly effective in preventing COVID-19.
While the broad architecture and organization of the human brain is universal, new research shows how the differences between how people reimagine common scenarios can be observed in brain activity ...
Oscine Therapeutics – a biotechnology company that is developing cell-based therapies for neurological disorders based on discoveries made at the University of Rochester Medical Center – has been ...
The Translational Immunology and Infectious Diseases Institute will focus on the development of new treatments and vaccines, and strategies to better control the spread of infectious diseases like ...
Irwin N. Frank, M.D. – one of the most influential urologists in the last half-century – has died at the age of 93. Frank, who spent his entire academic and medical career at the University of ...
Whether flu or coronavirus, it can take several days for the body to ramp up an effective response to a viral infection. New research appearing in the journal Nature Immunology describes how ...
New research details how the complex set of molecular and fluid dynamics that comprise the glymphatic system – the brain’s unique process of waste removal – are synchronized with the master internal ...
The University of Rochester Medical Center is joining a phase 3 clinical trial for a potential coronavirus vaccine being developed by AstraZeneca and the University of Oxford known as AZD1222.
Biological sex is typically understood in binary terms: male and female. However, a new study identifies a genetic switch in brain cells that can toggle between sex-specific states when necessary, ...
The University of Rochester Medical Center (URMC) and Rochester Regional Health (RRH) are joining a phase 3 clinical trial for a potential coronavirus vaccine developed by Pfizer and BioNTech. Four ...
URMC has been designated an Intellectual and Developmental Disabilities Research Center by the National Institutes of Health. The award recognizes the Medical Center’s national leadership in research ...
Long-term care facilities with lower nurse staffing levels, poorer quality scores, and higher concentrations of disadvantaged residents suffer from higher rates of confirmed COVID-19 cases, according ...
The University of Rochester Medical Center (URMC) and Rochester Regional Health (RRH) are investigating a new potential coronavirus vaccine developed by Pfizer and BioNTech. “COVID-19 is a highly ...
Cerebral edema, swelling that occurs in the brain, is a severe and potentially fatal complication of stroke. New research, which was conducted in mice and appears in the journal Science, shows for ...
Read about professors in the School of Nursing, Department of Neurology, and Department of Psychology who are harnessing state-of-the-art technology and data science to advance our knowledge of the ...
New research appearing in the journal Scientific Reports unpacks the list of chemicals that comprise flavored e-liquids and pods used in vaping and details their harmful effects to lung tissue, ...
One of the potentially life-altering side effects that patients experience after cranial radiotherapy for brain cancer is cognitive impairment. Researchers now believe that they have pinpointed why ...
Science tells us that a lot of good things happen in our brains while we sleep – learning and memories are consolidated and waste is removed, among other things. New research shows for the first time ...
University of Rochester Medical Center researchers have been selected as part of a national initiative by the National Institutes of Health to develop new non-addictive treatments for pain to improve ...
New research shows that maternal exposure to a common and ubiquitous form of industrial pollution can harm the immune system of offspring and that this injury is passed along to subsequent ...
A new book details the insights learned from communities that came together to overcome long-standing and seemingly insurmountable environmental public health challenges. Using three case studies, ...
The UR Medicine Mobile Stroke Unit (MSU) is now being dispatched to provide stroke care to patients throughout Monroe County. The MSU had been operating on a pilot basis in the City of Rochester ...
URMC researchers have compiled decades of patient data and developed a highly sensitive rating scale that has provided a detailed picture of Batten disease.
Very little is known about how the onset of puberty is controlled in humans, but the discovery of a new gene in the roundworm C. elegans could be the "missing link" that determines when it's time to ...
Two new grants from the National Institute of Neurological Disorders and Stroke (NINDS) will pave the way for new treatments for neuronal ceroid lipofuscinoses and Charcot Marie Tooth diseases, two ...
Oscine Therapeutics, a new biotechnology company based on discoveries made and developed at the University of Rochester Medical Center has received a significant multi-year investment to support both ...
The University of Rochester Medical Center has been tapped as one of the first institutions in the U.S. to offer a new gene replacement therapy to treat spinal muscular atrophy. The new treatment, ...